ASH1L mediated transcription networks in autism spectrum disorders
ASH1L mediated transcription networks in autism spectrum disorders
批准号:
10819810
负责人:
Judy Shih-Hwa Liu
金额:
$3.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-01-01 至 2026-12-31
关键词:
ASH1L geneAdministrative SupplementAdmission activityAnatomyBioinformaticsBrainCellsChromatin Remodeling FactorCommunicationDoctor of PhilosophyElementsEpigenetic ProcessEthicsExposure toFOXP1 geneFunctional disorderFundingGene ExpressionGenesGenetic Predisposition to DiseaseGenetic TranscriptionHistological TechniquesLinkMediatingMicroscopyMolecularMorphogenesisMorphologyMusMutant Strains MiceMutationNeuronal DysfunctionNeuronsNeurosciences ResearchPhenotypePolycombPostbaccalaureatePreparationResearchResearch AssistantResearch TrainingRisk FactorsRoleStructureTestingTrainingTranscriptional RegulationTranslational Researchautism spectrum disordercareer developmentdisease phenotypeexperiencegenetic risk factorhigh riskhistone methyltransferaseinsightmutantneuron developmentnovelprogramsrisk variantsymposiumsynaptic functiontranscription factortranscriptomics
中文摘要
项目总结
英文摘要
Project Summary
Autism spectrum disorder (ASD) research has led to the discovery of highly penetrant mutations in chromatin
modifiers and transcription factors. However, given the large number of ASD risk factors, a major challenge for
ASD research is to establish convergent mechanisms that group apparently distinct genetic etiologies. We
identified a novel point of convergence between the histone-methyltransferase ASH1L, a major ASD genetic
risk factor, and a cluster of ASD high-risk genes (e.g. FOXP1, RIMS1, NRX1α). Transcriptional programs
modulated by ASH1L that lead to neuronal dysfunction are poorly understood. Our studies uncover a
transcriptional and epigenetic node linked to cell and circuit dysfunction underlying ASD phenotypes. Our
central hypothesis is that ASH1L counteracts Polycomb (PRC2) activity to orchestrate neuronal
development by modulating transcriptional programs governing synaptic function and neuronal
morphogenesis. We have observed that ASH1L-deficient neurons show significantly decreased levels of
FOXP1 expression, indicating transcriptional control of FOXP1 by ASH1L. It is therefore possible that this
relationship underlies overlapping features in the changes in brain structure and their associated transcriptional
networks caused by FOXP1 and ASH1L deficiency. In this Supplement, we will test the hypothesis that ASH1L
regulates transcriptional programs mediated by its downstream target, FOXP1, via inhibition of PRC2
activity. We will determine how FOXP1 contributes to the ASH1L mutant phenotype in two Aims. In Aim 1, we
will identify convergent and divergent mechanisms by characterizing the morphological and anatomical
phenotypes of ASH1L and FOXP1 mutant mouse brains. In Aim 2, we will define the relationship between
ASH1L and FOXP1 neuronal transcriptional networks, including the involvement of PRC2, by performing
transcriptomic analysis of ASH1L and FOXP1-deficient mouse brains. These Aims will not only provide clearer
insight into our studies of ASH1L-mediated mechanisms of neuronal development, but also constitute the
research training component of this Diversity Supplement for our post-baccalaureate research assistant. Funds
from the Supplement will allow our research assistant to integrate into our ASH1L research team while gaining
bench experience in histological techniques and advanced microscopy, molecular expression analysis and
bioinformatics. Along with conference activities and exposure to rigor, ethics, scientific communication and
elements of translational research, our assistant will receive career development training and guidance in
preparation for admission to a strong MD/PhD program in neuroscience research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ASH1L mediated transcription networks in autism spectrum disorders
-
批准号:10733409
-
项目类别:
-
资助金额:$90.61万
-
财政年份:2023
-
负责人:Judy Shih-Hwa Liu
-
依托单位:
ASH1L mediated transcription networks in autism spectrum disorders
-
批准号:10446686
-
项目类别:
-
资助金额:$76.05万
-
财政年份:2022
-
负责人:Judy Shih-Hwa Liu
-
依托单位:
The Circadian Molecular Clock is a Biomarker for Epilepsy in Focal Cortical Dysplasia
-
批准号:10351603
-
项目类别:
-
资助金额:$7.72万
-
财政年份:2021
-
负责人:Judy Shih-Hwa Liu
-
依托单位:
The Circadian Molecular Clock is a Biomarker for Epilepsy in Focal Cortical Dysplasia
-
批准号:10302615
-
项目类别:
-
资助金额:$8.14万
-
财政年份:2019
-
负责人:Judy Shih-Hwa Liu
-
依托单位:
The Circadian Molecular Clock is a Biomarker for Epilepsy in Focal Cortical Dysplasia
-
批准号:10625052
-
项目类别:
-
资助金额:$8.16万
-
财政年份:2019
-
负责人:Judy Shih-Hwa Liu
-
依托单位:
The Circadian Molecular Clock is a Biomarker for Epilepsy in Focal Cortical Dysplasia
-
批准号:10093151
-
项目类别:
-
资助金额:$43.15万
-
财政年份:2019
-
负责人:Judy Shih-Hwa Liu
-
依托单位:
The Circadian Molecular Clock is a Biomarker for Epilepsy in Focal Cortical Dysplasia
-
批准号:10334417
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2019
-
负责人:Judy Shih-Hwa Liu
-
依托单位:
海外基金